0001209191-17-057667.txt : 20171020
0001209191-17-057667.hdr.sgml : 20171020
20171020172329
ACCESSION NUMBER: 0001209191-17-057667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171018
FILED AS OF DATE: 20171020
DATE AS OF CHANGE: 20171020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pope Todd
CENTRAL INDEX KEY: 0001584367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 171147720
MAIL ADDRESS:
STREET 1: C/O TRANSENTERIX
STREET 2: 635 DAVIS DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-18
0
0000876378
TRANSENTERIX INC.
TRXC
0001584367
Pope Todd
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
1
1
0
0
President and CEO
Common Stock
2017-10-18
4
M
0
95335
0.35
A
462644
D
Common Stock
2017-10-18
4
M
0
287356
0.35
A
750000
D
Common Stock
2017-10-18
4
S
0
600000
3.68
D
150000
D
Stock Option
0.35
2017-10-18
4
M
0
95335
0.00
D
2013-12-14
2019-12-14
Common Stock
95335
0
D
Stock Option
0.35
2017-10-18
4
M
0
287356
0.00
D
2015-02-02
2022-04-12
Common Stock
287356
138555
D
The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.46 to $4.23 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
/s/ Joshua Weingard as attorney-in-fact for Todd M Pope
2017-10-20